SCROLL DOWN FOR THE LATEST PRESS RELEASES AND TWEETS - For media enquiries about any aspect of the work of the PMCPA please contact the Press Office via the switchboard: 020 7747 8880 or email us at firstname.lastname@example.org - Sign up for eAlerts at the top of the page and follow us on Twitter @PMCPAUK
The PMCPA publishes certain Sanctions (advertisements, public reprimands and corrective statements) Press Releases and Case Reports.
- the carrying out by the PMCPA of an audit of a company’s procedures to comply with the Code. This can also be followed by a requirement that promotional material be submitted to the PMCPA for pre-vetting for a specified period
- requiring the company to take steps to recover items from those to whom they have been given
- requiring the company to issue a corrective statement
- a public reprimand
- suspension or expulsion from membership of the ABPI.
Where companies are ruled in breach of Clause 2 of the Code, and/or are required to issue a corrective statement and/or are the subject of a public reprimand, the PMCPA advertises brief details of the cases in the medical, nursing and pharmaceutical press, the advertisements are also published on this website.
Case Reports (access Case Reports here)
As mentioned above, in some cases a company may be required to issue a corrective statement or may be the subject of a public reprimand or advertisements in the medical and pharmaceutical press.
LEO Pharma, Norgine, Daiichi-Sankyo, Novartis, Sanofi, Consilient, and Pharmasure have been named in advertisements for breaches of the ABPI Code
02 August 2021read more
GUIDELINES ON COMPANY PROCEDURES RELATING TO THE 2021 ABPI CODE OF PRACTICE FOR THE PHARMACEUTICAL INDUSTRY
07 July 2021read more
New PMCPA Manager - Mr Keval Dabba
07 July 2021read more
2021 Interactive ABPI Code of Practice - Comes into operation 1 July 2021
28 June 2021read more
Consultation on Amendments to the mandatory template for the 2021 ABPI Code
08 June 2021read more
28 May 10:00 – 12:00: PMCPA webinar on forthcoming 2021 Code of Practice – for those not able to attend the series of webinars for pharmaceutical companies
27 April 2021read more